Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

1118

HTML

10083

Figures (1-4)

286

Tables (1-4)

226

Sum=11713

Publishing Process of This Article

Item

Count

Browse

784

Download

713

Sum=1497

Aug 6, 2013 (publication date) through Nov 6, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Nephrol. Aug 6, 2013; 2(3): 56-76
Published online Aug 6, 2013. doi: 10.5527/wjn.v2.i3.56

Full Size Figure Download Figure

Figure 4 Complement regulatory factors. CR1: Complement receptor 1; DAF: Decay-accelerating factor; MCP: Membrane cofactor of proteolysis.

Citation: Salvadori M, Bertoni E. Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations. World J Nephrol 2013; 2(3): 56-76
URL: https://www.wjgnet.com/2220-6124/full/v2/i3/56.htm
DOI: https://dx.doi.org/10.5527/wjn.v2.i3.56